These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34257376)

  • 1. A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
    Huruba M; Farcas A; Leucuta DC; Bucsa C; Sipos M; Mogosan C
    Sci Rep; 2021 Jul; 11(1):14375. PubMed ID: 34257376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders.
    Huruba M; Farcas A; Leucuta DC; Bucsa C; Mogosan C
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
    Arabyat RM; Raisch DW; McKoy JM; Bennett CL
    Expert Opin Drug Saf; 2015; 14(11):1653-60. PubMed ID: 26393387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.
    Leone R; Venegoni M; Motola D; Moretti U; Piazzetta V; Cocci A; Resi D; Mozzo F; Velo G; Burzilleri L; Montanaro N; Conforti A
    Drug Saf; 2003; 26(2):109-20. PubMed ID: 12534327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.
    Conforti A; Chiamulera C; Moretti U; Colcera S; Fumagalli G; Leone R
    Curr Drug Saf; 2007 Jan; 2(1):47-63. PubMed ID: 18690950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
    Bidell MR; Lodise TP
    Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.
    Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A
    Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.
    Oreagba IA; Oshikoya KA; Ogar C; Adefurin AO; Ibrahim A; Awodele O; Oni Y
    Pharmacol Res Perspect; 2017 Apr; 5(2):e00297. PubMed ID: 28357123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis.
    DE Nunzio C; Nacchia A; Lombardo R; Franco A; Cicione A; Trucchi A; Labella M; Bartoletti R; Simonato A; Ficarra V; Tubaro A
    Minerva Urol Nephrol; 2023 Jun; 75(3):374-380. PubMed ID: 36940165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.
    Bennett AC; Bennett CL; Witherspoon BJ; Knopf KB
    Expert Opin Drug Saf; 2019 Nov; 18(11):1055-1063. PubMed ID: 31500468
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database.
    Shu Y; Zhang Q; He X; Liu Y; Wu P; Chen L
    Front Pharmacol; 2022; 13():990241. PubMed ID: 36147351
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoroquinolone use in a rural practice.
    Kelly L; Schreiber YS; Hopko J; Kirkwood T; Kattini R; Poirier D; Madden S
    Can J Rural Med; 2021; 26(1):14-18. PubMed ID: 33380601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-induced tendinopathy: also occurring with levofloxacin.
    Fleisch F; Hartmann K; Kuhn M
    Infection; 2000; 28(4):256-7. PubMed ID: 10961538
    [No Abstract]   [Full Text] [Related]  

  • 16. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions.
    Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
    Jones SC; Budnitz DS; Sorbello A; Mehta H
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1099-106. PubMed ID: 23963962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone-associated tendinopathy.
    Tsai WC; Yang YM
    Chang Gung Med J; 2011; 34(5):461-7. PubMed ID: 22035890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
    Meng L; Huang J; Jia Y; Huang H; Qiu F; Sun S
    Int J Clin Pract; 2019 May; 73(5):e13331. PubMed ID: 30809871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.